HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Reels In Golden Caviar For Fishy Skin-Care Claims

This article was originally published in The Rose Sheet

Executive Summary

Skin-lightening claims appear to be on FDA's radar as it continues its crackdown on overreaching cosmetic marketing, issuing a warning letter to Golden Caviar Skin Care for statements promoting a whitening serum and cream, among other offerings. The company's Caviar Lifting and Firming Serum with Zinc also is an unapproved drug, based on claimed benefits including wound healing and acne relief, the agency says.


Related Content

FDA Warns Pharmagel, Updates Webpage On Drug-Claim Violations
FDA Warning To L’Oreal Creates Uncertainty For Anti-Redness, Dark Spot Treatments
How Not To Cross FTC: Attorneys Offer Advice For Cosmeceutical Marketers



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts